Should You Buy LHC Group, Inc. (LHCG)?

As industrywide interest jumped, specific money managers were leading the bulls’ herd. Iguana Healthcare Management, led by Stuart Weisbrod, created the biggest position in LHC Group, Inc. (NASDAQ:LHCG). Iguana Healthcare Management had $2.4 million invested in the company at the end of the quarter. Ken Griffin’s Citadel Investment Group also made a $0.4 million investment in the stock during the quarter. The other funds with new positions in the stock are Gavin Saitowitz and Cisco J. del Valle’s Springbok Capital, Paul Tudor Jones’ Tudor Investment Corp, and Joseph Edelman’s Perceptive Advisors.

Let’s go over hedge fund activity in other stocks similar to LHC Group, Inc. (NASDAQ:LHCG). These stocks are ePlus Inc. (NASDAQ:PLUS), Easterly Government Properties Inc (NYSE:DEA), Enviva Partners LP (NYSE:EVA), and The Gorman-Rupp Company (NYSEAMEX:GRC). This group of stocks’ market caps are similar to LHCG’s market cap.

As you can see these stocks had an average of 6 hedge funds with bullish positions and the average amount invested in these stocks was $30 million. That figure was $72 million in LHCG’s case. ePlus Inc. (NASDAQ:PLUS) is the most popular stock in this table. On the other hand Enviva Partners LP (NYSE:EVA) is the least popular one with only 2 bullish hedge fund positions. Compared to these stocks LHC Group, Inc. (NASDAQ:LHCG) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None